Damora Therapeutics, Inc. — 10-Q Filings
16 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Damora Therapeutics, Inc. (DMRA), sorted by most recent first. Each row links to the full filing on EdgarLookup. Damora Therapeutics, Inc. has filed 16 10-Q documents with the SEC since 2020. To view all SEC filings by Damora Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
4
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001193125-25-269426 | Nov 6, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-102963 | Aug 5, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-066884 | May 8, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0000950170-24-119809 | Nov 1, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-095383 | Aug 12, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-049808 | Apr 29, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0000950170-23-059367 | Nov 6, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-035925 | Jul 31, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-015461 | Apr 28, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0000950170-22-022935 | Nov 8, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-013434 | Jul 29, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-006612 | Apr 29, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0001564590-21-054462 | Nov 4, 2021 | Sep 30, 2021 |
| 10-Q | 10-Q | 0001564590-21-041147 | Aug 5, 2021 | Jun 30, 2021 |
| 10-Q | 10-Q | 0001564590-21-022987 | May 4, 2021 | Mar 31, 2021 |
| 10-Q | 10-Q | 0001564590-20-056793 | Dec 11, 2020 | Sep 30, 2020 |